Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Our AI drug discovery platform leverages public and proprietary biomedical data and features the world’s leading knowledge graph for rare diseases. Combining this technology with patient insights and drug discovery expertise, our mission is to advance 100 rare disease treatments towards the clinic by 2025.
B2C, B2B
26 to 50
Series B
$67.9M
Scaling Up
2014
Pharmaceuticals and Medical Products
Managed Health Care
Healthcare
Biotechnology
N/A
Increase Efficiency
Analytics
Service
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
Knowledge Representation and Reasoning
N/A
Software & Hardware
N/A
N/A
Apr 2021
- Healx Launches Partnership with Ataxia UK and FARA to Find Treatments for Rare Neurodegenerative Condition
Mar 2021
- Healx and The PKD Charity Collaborate to Apply AI to the Discovery of Novel Treatments for Rare Kidney Diseases
Aug 2017
- Healx Data Scientist Wins Poster Prize for Finding New Links Between Rare Diseases
Machine Learning Engineer
Cambridge, England
VP of Engineering
Cambridge, England
Senior Computational Systems Biologist (Bioinformatician)
Cambridge, England
Scientific Programmer
Cambridge, England
Principal Pharmacologist
Cambridge, England
